Oakworth Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Oakworth Capital’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	350	–	–	﹤0.01%	957
2026 Q1	$1	Hold	350	–	–	﹤0.01%	852
2025 Q4	$1	Hold	350	–	–	﹤0.01%	857
2025 Q3	$1	Buy	+350	New	+$1	﹤0.01%	837

Other funds holding SRNE

VWA

VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return

Oakworth Capital's SRNE Position: Q2 2026 in Review

Oakworth Capital held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q2 2026 at 350 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Oakworth Capital first reported a position in SRNE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1 in Q1 2026. 2 funds tracked by Wall St. Rank hold SRNE as of Q2 2026.

Oakworth Capital held 350 shares of Sorrento Therapeutics, Inc. worth $0 as of Q2 2026.
Oakworth Capital left its Sorrento Therapeutics, Inc. share count unchanged in Q2 2026.
Sorrento Therapeutics, Inc. made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #957 holding.
Oakworth Capital first reported a position in Sorrento Therapeutics, Inc. in Q3 2025 and has held it in 4 quarters since.
Oakworth Capital's Sorrento Therapeutics, Inc. position peaked at $1 in Q1 2026.
2 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.